0584617 - ÚMCH 2025 RIV NL eng J - Journal Article
Libánská, Alena - Randárová, Eva - Rubanová, Daniela - Skoroplyas, Svitlana - Bryja, Josef - Kubala, Lukáš - Konefal, Rafal - Navrátilová, A. - Cerezo, L. A. - Šenolt, L. - Etrych, Tomáš
Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases.
International Journal of Pharmaceutics. Roč. 654, 10 April (2024), č. článku 123979. ISSN 0378-5173. E-ISSN 1873-3476
R&D Projects: GA MZd(CZ) NU20-08-00255
Institutional support: RVO:61389013 ; RVO:68081707
Keywords : controlled drug release * polymer conjugates * HPMA
OECD category: Polymer science; Biochemistry and molecular biology (BFU-R)
Impact factor: 5.8, year: 2022
Method of publishing: Limited access
https://www.sciencedirect.com/science/article/pii/S0378517324002138?via%3Dihub
Permanent Link: https://hdl.handle.net/11104/0352524
Libánská, Alena - Randárová, Eva - Rubanová, Daniela - Skoroplyas, Svitlana - Bryja, Josef - Kubala, Lukáš - Konefal, Rafal - Navrátilová, A. - Cerezo, L. A. - Šenolt, L. - Etrych, Tomáš
Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases.
International Journal of Pharmaceutics. Roč. 654, 10 April (2024), č. článku 123979. ISSN 0378-5173. E-ISSN 1873-3476
R&D Projects: GA MZd(CZ) NU20-08-00255
Institutional support: RVO:61389013 ; RVO:68081707
Keywords : controlled drug release * polymer conjugates * HPMA
OECD category: Polymer science; Biochemistry and molecular biology (BFU-R)
Impact factor: 5.8, year: 2022
Method of publishing: Limited access
https://www.sciencedirect.com/science/article/pii/S0378517324002138?via%3Dihub
Permanent Link: https://hdl.handle.net/11104/0352524